Clinical Trials Browser

Phase 2 × Terminated × futuximab × Clear all

NCT03549338 2020-09-28

Sym004 Versus Futuximab or Modotuximab in Patients With mCRC

Phase 2 Terminated

2 enrolled 9 charts

Gastrointestinal

Carcinoma, Colorectal Neoplasms